ClinicalTrials.Veeva

Menu

School Located Adolescent Vaccination Study

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Completed

Conditions

School Located Vaccine Program

Treatments

Behavioral: School Located Vaccine (SLV) Program

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT01719679
08-0204

Details and patient eligibility

About

The provision of adolescent vaccination in a school setting will be feasible and acceptable to parents as evidenced by the number and percentage of students immunized within each school compared to those in schools without a program. The likelihood of vaccination for diphtheria, tetanus, and pertussis (Tdap), human papillomavirus (HPV), and meningococcal conjugate vaccine (MCV4) and all three combined) among eligible students enrolled in schools with a comprehensive school-based immunization program will be significantly higher than that of students enrolled in schools without a school-based immunization program.

Enrollment

2,000 patients

Sex

All

Ages

10 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 2000 (1000 at intervention schools and 1000 in control schools) randomly selected students enrolled in 6th - 8th grade at randomly selected schools
  • students who appear to be in need of one or more immunizations of interest at the beginning of the school year
  • students enrolled in school by October 1st registration deadline will be included in the analysis

Exclusion criteria

  • students who appear to have had all immunizations of interest at the beginning of the school year
  • students enrolled after the October 1 school registration deadline will be excluded from the analysis
  • students enrolled in grades other than 6th, 7th, or 8th grade will not be eligible to participate

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,000 participants in 2 patient groups

School Located Vaccine (SLV) Program
Experimental group
Description:
A vaccine program carried out by a community vaccinator will be conducted in a limited number of participating schools. The program will be open to the students enrolled at the participating schools
Treatment:
Behavioral: School Located Vaccine (SLV) Program
no School Located Vaccine (SLV) Program
No Intervention group
Description:
Schools that are part of the non-intervention arm of the study will not have a school-located vaccine program.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems